• OPEN AN ACCOUNT
Indian Indices
Sensex
79,116.19 -1,122.66
( -1.40%)
Global Indices
Nasdaq
48,521.56 -404.23
(-0.83%)
Dow Jones
6,836.74 -65.88
(-0.95%)
Hang Seng
54,115.64 -2,163.41
(-3.84%)
Nikkei 225
10,473.49 -306.62
(-2.84%)
Forex
USD-INR
91.48 0.43
(0.47%)
EUR-INR
107.28 -0.27
(-0.25%)
GBP-INR
122.62 -0.09
(-0.07%)
JPY-INR
0.58 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524804
INE406A01037
369.1611632
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AUROPHARMA
32.82
70355.4
EPS(TTM)
Face Value()
Div & Yield %
36.91
1
0
 

accedere ltd
Accedere consolidated net profit declines 20.00% in the September 2025 quarter
Oct 29,2025
Net profit of Accedere declined 20.00% to Rs 0.08 crore in the quarter ended September 2025 as against Rs 0.10 crore during the previous quarter ended September 2024. Sales declined 6.60% to Rs 0.99 crore in the quarter ended September 2025 as against Rs 1.06 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales0.991.06 -7
OPM %12.1216.98 -
PBDT0.120.18 -33
PBT0.090.14 -36
NP0.080.10 -20